The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AMBRX BIOPHARMA INC SPONSORED ADS 02290A102   274,694,949 16,688,636 SH   SOLE   16,688,636 0 0
ARGENX SE SPONSORED ADR 04016X101   106,529,967 273,343 SH   SOLE   273,343 0 0
TG THERAPEUTICS INC COM 88322Q108   230,476,425 9,278,439 SH   SOLE   9,278,439 0 0